Logotype for Philip Morris International Inc

Philip Morris International (PM) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Philip Morris International Inc

Q2 2024 earnings summary

8 Jul, 2026

Executive summary

  • Achieved record first-half organic top-line and operating income growth, driven by strong performance in smoke-free products, especially IQOS and ZYN, across multiple regions, despite supply constraints and regulatory headwinds.

  • Diluted EPS increased 27.5% year-over-year to $2.92, with adjusted diluted EPS up 10.6% in Q2 excluding currency impacts, reflecting robust operating income and margin expansion.

  • Smoke-free products accounted for over 38% of net revenues, with 36.5 million adult users globally, and ZYN and IQOS leading growth.

  • Full-year guidance was raised for organic net revenue, operating income, and EPS, despite significant currency and regulatory headwinds.

  • Net cash from operating activities more than doubled to $4.9 billion, supported by improved working capital and higher earnings.

Financial highlights

  • Net revenues for H1 2024 rose 7.5% to $18.3 billion, with Q2 organic net revenue up 9.6% and shipment volume growth of 2.8%.

  • Adjusted diluted EPS for Q2 was $1.59, up 10.6% excluding currency, and H1 adjusted diluted EPS grew 16.8% in constant currency.

  • Operating income grew 22.5% to $6.5 billion in H1, with margin expansion supported by pricing, volume/mix, and lower impairment charges.

  • Gross margin increased to 64.2% for six months, up 1.1 percentage points year-over-year.

  • Net cash from operating activities for six months was $4.9 billion, up from $2.5 billion.

Outlook and guidance

  • Raised 2024 guidance: organic net revenue growth forecast at 7.5%–9%, organic operating income growth at 11%–13%, and adjusted diluted EPS growth at 11%–13% excluding currency.

  • Full-year adjusted diluted EPS expected at $6.33–$6.45, with reported diluted EPS forecasted at $5.89–$6.01.

  • Q3 adjusted diluted EPS forecasted at $1.77–$1.82.

  • Full-year operating cash flow expected around $11 billion, with capex of $1.3–$1.4 billion.

  • HTU shipment volumes expected around 140 billion units for 2024; U.S. nicotine pouch shipments of 560–580 million cans.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more